🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Daptomycin - Medicines in Ireland

16 authorised products containing Daptomycin, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 16 authorised medicines
MedicineActive substanceLicence holderStatus
Cubicin 350 mg powder for solution for injection or infusion
EU/1/05/328/001
 Daptomycin Merck Sharp & Dohme BV —
Cubicin 500 mg powder for solution for injection or infusion
EU/1/05/328/002
 Daptomycin Merck Sharp & Dohme BV —
Daptomycin 350 mg powder for solution for injection/infusion
PA23092/004/001
 Daptomycin Reddy Holding GmbH Marketed
Daptomycin 350 mg powder for solution for injection/infusion
PA2237/005/001
 Daptomycin hameln pharma gmbh Not marketed
Daptomycin 500 mg powder for solution for injection/infusion
PA23092/004/002
 Daptomycin Reddy Holding GmbH Marketed
Daptomycin 500 mg powder for solution for injection/infusion
PA2237/005/002
 Daptomycin hameln pharma gmbh Not marketed
Daptomycin Accord Healthcare 350 mg powder for solution for injection/infusion
PA2315/258/001
 Daptomycin Accord Healthcare Ireland Ltd. Not marketed
Daptomycin Accord Healthcare 500 mg powder for solution for injection/infusion
PA2315/258/002
 Daptomycin Accord Healthcare Ireland Ltd. Not marketed
Daptomycin Accordpharma 350 mg powder for solution for injection/infusion
PA2315/237/001
 Daptomycin Accord Healthcare Ireland Ltd. Marketed
Daptomycin Accordpharma 500 mg powder for solution for injection/infusion
PA2315/237/002
 Daptomycin Accord Healthcare Ireland Ltd. Marketed
Daptomycin Hospira 350 mg powder for solution for injection/infusion
EU/1/17/1175/001-002
 Daptomycin Pfizer Europe MA EEIG —
Daptomycin Hospira 500 mg powder for solution for injection/infusion
EU/1/17/1175/003-004
 Daptomycin Pfizer Europe MA EEIG —
Daptomycin Noridem 350 mg Powder for solution for injection/infusion
PA1122/021/001
 Daptomycin Noridem Enterprises Limited Marketed
Daptomycin Noridem 500 mg Powder for solution for injection/infusion
PA1122/021/002
 Daptomycin Noridem Enterprises Limited Marketed
Daptomycin Xellia 350 mg powder for solution for injection/infusion
PA1982/003/001
 Daptomycin Xellia Pharmaceuticals ApS Not marketed
Daptomycin Xellia 500 mg powder for solution for injection/infusion
PA1982/003/002
 Daptomycin Xellia Pharmaceuticals ApS Not marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.